AGL EBITDA
Agilon Health · EBITDA
AGL EBITDA
Latest reported$11.22Mperiod ending
AGL Quarterly EBITDA (-$58.44M → $11.22M)
Quarterly EBITDA
High-resolution chart · PNG
AGL ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 11,215,000 | |
| 34,920,000 | |
| -178,873,000 | |
| -101,270,000 | |
| -95,417,000 | |
| 6,699,000 | |
| -96,605,000 | |
| -109,182,000 | |
| -22,641,000 | |
| 10,242,000 | |
| -155,634,000 | |
| -13,902,000 | |
| -7,883,000 | |
| 13,874,000 | |
| -50,326,000 | |
| -25,494,000 | |
| -16,471,000 | |
| 4,899,000 | |
| -52,769,000 | |
| -31,933,000 | |
| -291,782,000 | |
| -7,298,000 | |
| -33,104,000 | |
| -6,812,000 | |
| 2,156,000 | |
| -2,349,000 | |
| -58,438,000 |